Literature DB >> 21469086

The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21.

Dimitrios Iliopoulos1, Melina Kavousanaki, Marianna Ioannou, Dimitrios Boumpas, Panayotis Verginis.   

Abstract

Disruption of the programmed death-1 (PD-1) pathway leads to breakdown of peripheral tolerance and initiation of autoimmunity. The molecular pathways that mediate this effect remain largely unknown. We report here that PD-1 knockout (PD-1(-/-) ) mice develop more severe and sustained Ag-induced arthritis (AIA) than WT animals, which is associated with increased T-cell proliferation and elevated levels of IFN-γ and IL-17 secretion. MicroRNA analysis of Ag-specific CD4(+) T cells revealed a significant upregulation of microRNA 21 (miR-21) in PD-1(-/-) T cells compared with WT controls. In addition, PD-1 inhibition, via siRNA, upregulated miR-21 expression and enhanced STAT5 binding in the miR-21 promoter area. Computational analysis confirmed that miR-21 targets directly the expression of programmed cell death 4 (PDCD4) and overexpression of miR-21 in cells harboring the 3'UTR of PDCD4 resulted in reduced transcription and PDCD4 protein expression. Importantly, in vitro delivery of antisense-miR-21 suppressed the Ag-specific proliferation and cytokine secretion by PD-1(-/-) T cells, whereas adoptive transfer of Ag-specific T cells, overexpressing miR-21, induced severe AIA. Collectively, our data demonstrate that breakdown of tolerance in PD-1(-/-) mice activates a signaling cascade mediated by STAT5, miR-21, and PDCD4 and establish their role in maintaining the balance between immune activation and tolerance.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469086     DOI: 10.1002/eji.201040646

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

Review 1.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.

Authors:  Sasagu Kurozumi; Yuri Yamaguchi; Masafumi Kurosumi; Miki Ohira; Hiroshi Matsumoto; Jun Horiguchi
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

2.  High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function.

Authors:  Ioanna Tiniakou; Elias Drakos; Vaios Sinatkas; Miranda Van Eck; Vassilis I Zannis; Dimitrios Boumpas; Panayotis Verginis; Dimitris Kardassis
Journal:  J Immunol       Date:  2015-04-13       Impact factor: 5.422

Review 3.  microRNAs function in CD8+T cell biology.

Authors:  Yan Liang; Hai-Feng Pan; Dong-Qing Ye
Journal:  J Leukoc Biol       Date:  2015-01-05       Impact factor: 4.962

Review 4.  Enhancing adoptive T cell immunotherapy with microRNA therapeutics.

Authors:  Yun Ji; James D Hocker; Luca Gattinoni
Journal:  Semin Immunol       Date:  2015-12-20       Impact factor: 11.130

Review 5.  Implications of microRNA 21 and its involvement in the treatment of different type of arthritis.

Authors:  Durairaj Sekar
Journal:  Mol Cell Biochem       Date:  2020-11-02       Impact factor: 3.396

Review 6.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

7.  Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response.

Authors:  Lifen Yang; Guilin Qiao; Yassir Hassan; Zhenping Li; Xiaoqing Zhang; Huimin Kong; Weimin Zeng; Fei Yin; Jian Zhang
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-05-19       Impact factor: 4.291

8.  Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.

Authors:  Yugo Ando; Guo-Xiang Yang; Thomas P Kenny; Kazuhito Kawata; Weici Zhang; Wenting Huang; Patrick S C Leung; Zhe-Xiong Lian; Kazuichi Okazaki; Aftab A Ansari; Xiao-Song He; Pietro Invernizzi; William M Ridgway; Qianjin Lu; M Eric Gershwin
Journal:  J Autoimmun       Date:  2013-02-08       Impact factor: 7.094

Review 9.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

10.  The role of epigenetic mechanisms and processes in autoimmune disorders.

Authors:  Judith M Greer; Pamela A McCombe
Journal:  Biologics       Date:  2012-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.